Species
|
Resource
|
RRC ID
|
Title
|
Journal
|
Published
|
Link
|
Human and Animal Cells
|
A431(RCB0202)
|
77840
|
Involvement of EGFR in the response of squamous cell carcinoma of the head and neck cell lines to gefitinib.
|
Oncol Rep |
2008-1-1 |
Pubmed
|
Human and Animal Cells
|
A549(RCB0098)
,
LC-2/ad(RCB0440)
,
RERF-LC-KJ(RCB1313)
|
68848
|
MiR-134/487b/655 cluster regulates TGF-β-induced epithelial-mesenchymal transition and drug resistance to gefitinib by targeting MAGI2 in lung adenocarcinoma cells.
|
Mol Cancer Ther |
2014-2-1 |
Pubmed
Full text
|
Human and Animal Cells
|
PC-9(RCB4455)
|
68847
|
Gefitinib induces premature senescence in non-small cell lung cancer cells with or without EGFR gene mutation.
|
Oncol Rep |
2007-2-1 |
Pubmed
|
Human and Animal Cells
|
RERF-LC-KJ(RCB1313)
,
LC-1/sq(RCB0455)
,
RERF-LC-AI(RCB0444)
,
MS-1(RCB0725)
|
68846
|
PTEN inactivation in lung cancer cells and the effect of its recovery on treatment with epidermal growth factor receptor tyrosine kinase inhibitors.
|
Int J Oncol |
2007-11-1 |
Pubmed
|
Human and Animal Cells
|
PC-9(RCB4455)
|
68845
|
Amino acid starvation culture condition sensitizes EGFR-expressing cancer cell lines to gefitinib-mediated cytotoxicity by inducing atypical necroptosis.
|
Int J Oncol |
2018-4-1 |
Pubmed
Full text
|
Human and Animal Cells
|
PC-9(RCB4455)
|
68836
|
Lack of AKT activation in lung cancer cells with EGFR mutation is a novel marker of cetuximab sensitivity.
|
Cancer Biol Ther |
2012-4-1 |
Pubmed
Full text
|
Human and Animal Cells
|
PC-9(RCB4455)
|
67813
|
Favorable effect of the combination of vinorelbine and dihydropyrimidine dehydrogenase‑inhibitory fluoropyrimidine in EGFR‑mutated lung adenocarcinoma: retrospective and in vitro studies.
|
Int J Oncol |
2015-3-1 |
Pubmed
Full text
|
Human and Animal Cells
|
II-18(RCB2093)
|
67190
|
A peptide antigen derived from EGFR T790M is immunogenic in non‑small cell lung cancer.
|
Int J Oncol |
2015-2-1 |
Pubmed
Full text
|
Human and Animal Cells
|
MRC-5(RCB0218)
|
65828
|
MET Copy Number Gain Is Associated with Gefitinib Resistance in Leptomeningeal Carcinomatosis of EGFR-mutant Lung Cancer.
|
Mol Cancer Ther |
2017-3-1 |
Pubmed
Full text
|
Human and Animal Cells
|
RERF-LC-AI(RCB0444)
,
RERF-LC-KJ(RCB1313)
,
LC-2/ad(RCB0440)
,
A549
|
65430
|
Contrasting Effects of the Cytotoxic Anticancer Drug Gemcitabine and the EGFR Tyrosine Kinase Inhibitor Gefitinib on NK Cell-Mediated Cytotoxicity via Regulation of NKG2D Ligand in Non-Small-Cell Lung Cancer Cells.
|
PLoS One |
2015-1-1 |
Pubmed
Full text
|
Human and Animal Cells
|
293T(RCB2202)
,
TE-1(RCB1894)
,
TE-11(RCB2100)
,
TE-14(RCB2101)
,
TE-15(RCB1951)
|
65166
|
ANO1/TMEM16A interacts with EGFR and correlates with sensitivity to EGFR-targeting therapy in head and neck cancer.
|
Oncotarget |
2015-4-20 |
Pubmed
Full text
|
Human and Animal Cells
|
PC-9(RCB4455)
|
64523
|
The impact of intermittent versus continuous exposure to EGFR tyrosine kinase inhibitor on selection of EGFR T790M-mutant drug-resistant clones in a lung cancer cell line carrying activating EGFR mutation.
|
Oncotarget |
2016-7-12 |
Pubmed
Full text
|
Human and Animal Cells
|
SSP-25(RCB1293)
,
HuH-28(RCB1943)
|
61794
|
Lovastatin overcomes gefitinib resistance through TNF-α signaling in human cholangiocarcinomas with different LKB1 statuses in vitro and in vivo.
|
Oncotarget |
2015-9-15 |
Pubmed
Full text
|
Human and Animal Cells
|
HSC-2(RCB1945)
,
HSC-3(RCB1975)
,
SAS(RCB1974)
,
Ca9-22(RCB1976)
|
56017
|
Combined SN-38 and gefitinib treatment promotes CD44 degradation in head and neck squamous cell carcinoma cells.
|
Oncol Rep |
2018-1-1 |
Pubmed
Full text
|
Human and Animal Cells
|
A549
|
55911
|
Elevation of sensitivity to anticancer agents of human lung adenocarcinoma A549 cells by knockdown of claudin-2 expression in monolayer and spheroid culture models.
|
Biochim Biophys Acta Mol Cell Res |
2018-3-1 |
Pubmed
Full text
|
Human and Animal Cells
|
293T(RCB2202)
|
55906
|
Combined effect of cabozantinib and gefitinib in crizotinib-resistant lung tumors harboring ROS1 fusions.
|
Cancer Sci |
2018-10-1 |
Pubmed
Full text
|
Human and Animal Cells
|
II-18(RCB2093)
|
52298
|
Glucose metabolism-targeted therapy and withaferin A are effective for epidermal growth factor receptor tyrosine kinase inhibitor-induced drug-tolerant persisters.
|
Cancer Sci |
2017-7-1 |
Pubmed
Full text
|
Human and Animal Cells
|
293(RCB1637)
|
51973
|
Up-Regulation of Transient Receptor Potential Melastatin 6 Channel Expression by Tumor Necrosis Factor-α in the Presence of Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor.
|
J Cell Physiol |
2017-10-1 |
Pubmed
Full text
|
Human and Animal Cells
|
LC-2/ad(RCB0440)
|
51943
|
EGF Induced RET Inhibitor Resistance in CCDC6-RET Lung Cancer Cells.
|
Yonsei Med J |
2017-1-1 |
Pubmed
Full text
|
Human and Animal Cells
|
PC-9(RCB4455)
|
51659
|
Drug resistance originating from a TGF-β/FGF-2-driven epithelial-to-mesenchymal transition and its reversion in human lung adenocarcinoma cell lines harboring an EGFR mutation.
|
Int J Oncol |
2016-5-1 |
Pubmed
Full text
|